scholarly journals Aortic Pathology Determines Midterm Outcome After Endovascular Repair of the Thoracic Aorta. Report from the Medtronic Thoracic Endovascular Registry (MOTHER) Database

2013 ◽  
Vol 57 (5) ◽  
pp. 1449
Author(s):  
B. Patterson ◽  
P. Holt ◽  
C. Nienaber
Circulation ◽  
2013 ◽  
Vol 127 (1) ◽  
pp. 24-32 ◽  
Author(s):  
Benjamin Patterson ◽  
Peter Holt ◽  
Chrisoph Nienaber ◽  
Richard Cambria ◽  
Ronald Fairman ◽  
...  

2007 ◽  
Vol 41 (3) ◽  
pp. 186-191 ◽  
Author(s):  
Michael W. A. Chu ◽  
Thomas L. Forbes ◽  
D. Kirk Lawlor ◽  
Kenneth A. Harris ◽  
Guy DeRose

Thoracic aorta disease remains a challenging problem, and despite improvements, open repair techniques are still associated with significant morbidity and mortality. This is a retrospective review of 53 consecutive patients with thoracic aortic pathology who were treated with endovascular repair between September 1998 and December 2004 at a tertiary-care hospital. Endovascular stent graft placement was performed on 23 elective and 30 emergent patients (34 male patients, mean age 66 years, 21 to 85 years). Completion angiography revealed no endoleak in 47 (89%) patients, a type I endoleak in 4 patients, and a type II endoleak in 2 patients. Operative 30-day mortality for elective aneurysms (n = 22), emergent aneurysms (n = 10), dissection (n = 3), penetrating aortic ulcers (n = 7), and trauma (n = 11) was 0%, 40%, 0%, 29%, and 9%, respectively. In total, 46 (87%) patients survived 30 days, and 36 (78.3%) of the survivors were discharged home free of complications. Two patients (4%) experienced paraplegia. Median follow-up was 22 months (1 to 72 months). Intermediate-term results revealed 41 (89%) patients free of endoleak, stent migration, or aneurysmal expansion. Two (4%) patients required reintervention with an additional stent graft. There were 2 (4%) patients with late aortic-related deaths and four (9%) patients with non—aorticrelated late deaths. Endovascular stent graft placement for thoracic aorta disease can be performed successfully and safely with good perioperative and intermediate-term outcomes. Stent graft complication and reintervention rates are low, whereas intermediate survival rates are good. Long-term efficacy still needs to be evaluated.


2006 ◽  
Vol 96 (3) ◽  
pp. 310-316 ◽  
Author(s):  
K Plaschke ◽  
D Boeckler ◽  
H Schumacher ◽  
E Martin ◽  
H.J. Bardenheuer

2019 ◽  
Vol 56 ◽  
pp. 202-208 ◽  
Author(s):  
Dimitrios Kapetanios ◽  
Christos D. Karkos ◽  
Ioannis Pliatsios ◽  
Maria Mitka ◽  
Ioakeim T. Giagtzidis ◽  
...  

2009 ◽  
Vol 66 (3) ◽  
pp. E36-E38 ◽  
Author(s):  
Ian F. Faneyte ◽  
J Carel Goslings ◽  
Krijn P. van Lienden ◽  
Mirza M. Idu

2020 ◽  
Vol 60 (3) ◽  
pp. 386-393 ◽  
Author(s):  
Okano Ryoi ◽  
Chia-Hsun Lin ◽  
Jian-Ming Chen ◽  
Yung-Kun Hsieh ◽  
Shoei-Shen Wang ◽  
...  

Author(s):  
Ourania Preventza ◽  
Grayson H. Wheatley ◽  
James Williams ◽  
Hannan Chaugle ◽  
Kakra Hughes ◽  
...  

Objective Routine preoperative carotid-subclavian bypass or transposition is frequently recommended in patients undergoing endovascular repair of the descending thoracic aorta (DTA). We reviewed our comprehensive thoracic endografting experience with regards to coverage of the left subclavian artery (LSA) to assess whether mandatory preoperative carotid-subclavian bypass or transposition is necessary. Methods Between February 2000 and November 2005, 255 patients were successfully treated with an endoluminal graft (ELG) to the DTA. Indications for intervention included atherosclerotic aneurysms (109/255, 42.7%), acute and chronic dissections (75/255, 29.4%), miscellaneous (41/255, 16.1%), and penetrating aortic ulcers (30/255, 11.8%). There were 151 males (151/255, 59.2%) and 104 females (104/255, 40.8%) with a mean age of 71 years (range, 23–91 years). Results The LSA was completely covered with an ELG in 71 patients (71/255, 27.8%) and partially covered in 47 patients (47/255, 18.4%). In patients who had complete coverage of the LSA, 30 patients (30/71, 42.3%) had acute or chronic Type B dissections, 26 patients (26/71, 36.6%) had aneurysms, 11 patients (11/71, 15.5%) had miscellaneous aortic pathologies, and 4 patients (4/71, 5.6%) had pseudoaneurysms associated with prior coarctation repair. Fifteen patients (15/255, 5.9%) underwent preoperative carotid-subclavian bypass or transposition and subsequently underwent complete coverage of the LSA with an ELG. One patient (1/56, 1.8%) with complete coverage of the LSA required elective postoperative carotid-subclavian bypass secondary to left arm claudication. Conclusions Routine preoperative carotid-subclavian bypass is not necessary, except in select patients with a patent left internal mammary artery to the left anterior descending artery bypass graft or contralateral vertebral artery disease.


2009 ◽  
Vol 38 (4) ◽  
pp. 408-421 ◽  
Author(s):  
H. Rousseau ◽  
V. Chabbert ◽  
M.A. Maracher ◽  
O. El Aassar ◽  
J. Auriol ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document